Ocriplasmin for Treatment of Vitreomacular Traction: An Update

Ophthalmology and Therapy - United Kingdom
doi 10.1007/s40123-016-0062-6
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Ocriplasmin Treatment for Vitreomacular Traction in Real Life: Can the Indication Spectrum Be Expanded?

Acta Ophthalmologica
MedicineOphthalmology
2017English

Ocriplasmin for the Treatment of Vitreomacular Traction and Macular Holes: Long-Term Modelling of Clinical and Economic Value of Resolution of Traction in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Vitreomacular Traction

2016English

Pss40 - Cost-Effectiveness of Ocriplasmin for the Treatment of Vitreomacular Traction, Including When Associated With Macular Hole: A Belgian Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Vitreomacular Traction Syndrome

Einstein (São Paulo, Brazil)
Medicine
2015English

Pss26 - Cost Effectiveness of Ocriplasmin for Treatment of Symptomatic Vitreomacular Adhesion in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Vitreomacular Traction Syndrome: New Non-Surgical Treatments

Revista Mexicana de Oftalmología (English Edition)
2019English

Pars Plana Vitrectomy for Treatment-Naïve Diabetic Macular Edema With or Without Vitreomacular Traction

Canadian Journal of Ophthalmology
MedicineOphthalmology
2018English

Vitreomacular Traction Affects Anti-Vascular Endothelial Growth Factor Treatment Outcomes for Exudative Age-Related Macular Degeneration

Retina
MedicineOphthalmology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy